相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Test-retest reliability and validity of the timed up and go test and 30-second sit to stand test in patients with pulmonary hypertension
Buse Ozcan Kahraman et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
Physical activity in incident patients with pulmonary arterial and chronic thromboembolic hypertension
Stephanie Saxer et al.
LUNG (2019)
The importance of patient perspectives in pulmonary hypertension
Michael D. McGoon et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Learning from registries in pulmonary arterial hypertension: pitfalls and recommendations
Katleen Swinnen et al.
EUROPEAN RESPIRATORY REVIEW (2019)
Evaluation of Clinical Outcomes and Simultaneous Digital Tracking of Daily Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Protocol for the Observational VENTASTEP Study
Christian Mueller et al.
JMIR RESEARCH PROTOCOLS (2019)
Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study
Manuel J. Richter et al.
PULMONARY CIRCULATION (2019)
lloprost delivered via the BREELIBTM nebulizer: a review of the clinical evidence for efficacy and safety
Tobias Gessler
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2019)
Respiratory muscle strength in patients with pulmonary hypertension: The relationship with exercise capacity, physical activity level, and quality of life
Goksen Kuran Aslan et al.
CLINICAL RESPIRATORY JOURNAL (2018)
The role of an activity monitor in the objective evaluation of patients with pulmonary hypertension
Gulfer Okumus et al.
CLINICAL RESPIRATORY JOURNAL (2018)
A study of clinical and physiological relations of daily physical activity in precapillary pulmonary hypertension
Marios Panagiotou et al.
JOURNAL OF APPLIED PHYSIOLOGY (2017)
Remote Monitoring of Patients With Heart Failure: An Overview of Systematic Reviews
Nazli Bashi et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2017)
The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension
Tobias Gessler et al.
PULMONARY CIRCULATION (2017)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
Efficacy and Safety of Inhaled Iloprost in Japanese Patients With Pulmonary Arterial Hypertension - Insights From the IBUKI and AIR Studies -
Tsutomu Saji et al.
CIRCULATION JOURNAL (2016)
Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement
Luis Puente-Maestu et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Sleep disturbance, symptoms, psychological distress, and health-related quality of life in pulmonary arterial hypertension
Lea Ann Matura et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING (2015)
Structured telephone support or non-invasive telemonitoring for patients with heart failure
Sally C. Inglis et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Physicians' and patients' expectations of therapies for pulmonary arterial hypertension: where do they meet?
Luke S. Howard et al.
EUROPEAN RESPIRATORY REVIEW (2014)
Riociguat for the Treatment of Pulmonary Arterial Hypertension
Hossein-Ardeschir Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Pulmonary arterial hypertension
David Montani et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Wrist Actigraphy Predicts Outcome in Patients with Pulmonary Hypertension
Silvia Ulrich et al.
RESPIRATION (2013)
Variability in physical activity patterns as measured by the SenseWear Armband: how many days are needed?
Tineke Scheers et al.
EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY (2012)
Assessment of Daily Life Physical Activities in Pulmonary Arterial Hypertension
Vincent Mainguy et al.
PLOS ONE (2011)
Evaluating Health-Related Quality of Life, Work Ability, and Disability in Pulmonary Arterial Hypertension An Unmet Need
Melvyn Rubenfire et al.
CHEST (2009)
Tadalafil therapy and health-related quality of life in pulmonary arterial hypertension
Joanna Pepke-Zaba et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Sildenafil improves health-related quality of life in patients with pulmonary arterial hypertension
Joanna Pepke-Zaba et al.
CHEST (2008)
Care Coordination/Home Telehealth: The Systematic Implementation of Health Informatics, Home Telehealth, and Disease Management to Support the Care of Veteran Patients with Chronic Conditions
Adam Darkins et al.
TELEMEDICINE JOURNAL AND E-HEALTH (2008)
Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension
Vallerie V. McLaughlin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension
S Provencher et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Health-related quality of life in patients with pulmonary arterial hypertension
DB Taichman et al.
RESPIRATORY RESEARCH (2005)
Outcomes of chronic heart failure
D Benatar et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Inhaled iloprost for severe pulmonary hypertension
H Olschewski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Sources of variance in daily physical activity levels as measured by an accelerometer
CE Matthews et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2002)